The Enhancement of Subcutaneous First-Pass Metabolism Causes Nonlinear Pharmacokinetics of TAK-448 after a Single Subcutaneous Administration to Rats
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.